JYMed Technology Co., Ltd. e thabetse ho phatlalatsa hore sehlahisoa sa eona, Tirzepatide, e atlehile ho phethela ngoliso ea Drug Master File (DMF) ho US FDA (Nomoro ea DMF: 040115) mme e amohetse Kananelo ea FDA ka Phato 2, 2024.
Tlhahiso ea Boima ka Boleng bo tsitsitseng
Ho latela batsamaisi ba phahameng ba JYMed Technology, tlhahiso e ngata ea Tirzepatide Active Pharmaceutical Ingredient (API) e ka fihla maemong a kilogram. Lihlopha tsa tlhahiso li tsitsitse ebile li tsoela pele, li na le phapang e fokolang pakeng tsa lihlopha, ho netefatsa boleng bo tsitsitseng.
Liphello tse Bohlokoa ho Phokotso ea Glucose le Lipid
Tirzepatide ke agonist ea pele ea lefats'e e amohetsoeng hang ka beke ea GIP/GLP-1. Joaloka li-agonists tse peli tsa li-receptor, ka nako e le 'ngoe e ka tlama le ho kenya tšebetsong li-receptor tse itšetlehileng ka tsoekere ea insulinotropic polypeptide (GIP) le GLP-1' meleng oa motho. Ntle le ho fokotsa maemo a tsoekere, e fokotsa ho ja lijo, boima ba 'mele le mafura,' me e laola tšebeliso ea lipid. Ntle le litlamorao tsa eona tsa bohlokoa tsa ho theola tsoekere le ho fokotsa boima ba 'mele, litlhahlobo tsa sehlopha se senyenyane ho tsoa letotong la liphuputso tsa SURPASS li bonts'itse hore Tirzepatide e boetse e ntlafatsa matšoao a metabolic joalo ka khatello ea mali, lipids ea mali, BMI le sedikadikwe sa letheka.
Litumello tsa Linaha Tse Ngata le Melemo e Tšepisang
Ho latela tlhaiso-leseling e nepahetseng, Mounjaro e theolang tsoekere e ile ea amoheloa ka lekhetlo la pele ke US FDA ka Mots'eanong 2022 bakeng sa kalafo ea batho ba baholo ba nang le lefu la tsoekere la mofuta oa 2. Ka mor'a moo e fumane tumello ho EU, Japane, le libakeng tse ling. Ka Pulungoana 2023, FDA e boetse e amohetse sesupo sa ho theola boima ba 'mele tlasa lebitso la brand Zepbound. Ka Mots'eanong 2024, e kene ka katleho 'marakeng oa China. Ka lebaka la tebello ea eona e pharaletseng ea ts'ebeliso le tlhaiso-leseling e matla ea lipatlisiso, Tirzepatide e fetohile e 'ngoe ea litlhare tse tsebahalang haholo tsa peptide kajeno. Theko ea eona e fihlile ho $ 5.163 bilione ka 2023, 'me kotara ea pele ea 2024 feela e bone thekiso ea $ 2.324 billion, e bonts'ang sekhahla se makatsang sa kholo.
Mabapi le JYMed
Shenzhen JYMed Technology Co., Ltd. (eo hamorao e tla bitsoa JYMed) e thehiloe ka 2009, e sebetsa ka thata ho etsa lipatlisiso, nts'etsopele, tlhahiso, le thekiso ea li-peptide le lihlahisoa tse amanang le peptide. Ka setsi se le seng sa lipatlisiso le metheo e meraro e meholo ea tlhahiso, JYMed ke e mong oa bahlahisi ba kholo ka ho fetisisa ba li-API tsa peptide tse entsoeng ka lik'hemik'hale Chaena. Sehlopha sa mantlha sa R&D sa k'hamphani se ithorisa ka boiphihlelo ba lilemo tse fetang 20 indastering ea peptide mme se atlehile ho feta tlhahlobo ea FDA habeli. Sistimi e pharalletseng le e sebetsang ea indasteri ea li-peptide ea JYMed e fa bareki mefuta e mengata ea lits'ebeletso, ho kenyelletsa nts'etsopele le tlhahiso ea li-peptide tsa kalafo, li-peptide tsa bongaka ba liphoofolo, li-peptide tse thibelang likokoana-hloko, le li-peptide tsa litlolo, hammoho le ngoliso le tšehetso ea taolo.
Mesebetsi e ka Sehloohong ea Khoebo
1.Ho ngolisoa ha li-peptide ka lapeng le tsa machaba
Li-peptide tsa 2.Veterinary le cosmetic
3.Custom peptides le CRO, CMO, OEM ditshebeletso
Lithethefatsi tsa 4.PDC (peptide-radionuclide, molek'hule e nyane ea peptide, protheine ea peptide, peptide-RNA)
Ntle le Tirzepatide, JYMed e kentse lifaele tsa ngoliso ho FDA le CDE bakeng sa lihlahisoa tse ling tse 'maloa tsa API, ho kenyelletsa le lithethefatsi tse tsebahalang tsa sehlopha sa GLP-1RA tse kang Semaglutide le Liraglutide. Bareki ba kamoso ba sebelisang lihlahisoa tsa JYMed ba tla khona ho supa ka kotloloho nomoro ea ngoliso ea CDE kapa nomoro ea faele ea DMF ha ba tlisa likopo tsa ho ingolisa ho FDA kapa CDE. Sena se tla fokotsa haholo nako e hlokahalang bakeng sa ho lokisa litokomane tsa kopo, hammoho le nako ea tlhahlobo le litšenyehelo tsa tlhahlobo ea sehlahisoa.
Iteanye le rona
Shenzhen JYMed Technology Co., Ltd.
Aterese:Mokatong oa borobeli le oa bo-9, Mohaho oa 1, Shenzhen Biomedical Innovation IndustrialPark, No. 14 Jinhui Road, Setereke-potlana sa Kengzi, Setereke sa Pingshan, Shenzhen
Mohala:+86 755-26612112
Webosaete: http://www.jymedtech.com/
Nako ea poso: Aug-12-2024